SCHEMBL23837332

SCHEMBL23837332

CNS(=O)(=O)CCC(=O)N[C@H]1Cc2cccc(C(=O)OCI)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23129663 0.92 TSHR (0.33) —
SCHEMBL17347664 0.92 TSHR (0.33) —
SCHEMBL23130160 0.90 — —
SCHEMBL23837482 0.89 — —
SCHEMBL23130157 0.89 — —
SCHEMBL17347760 0.88 PRKCB (0.32) —
SCHEMBL23129660 0.88 PRKCB (0.32) —
SCHEMBL17336987 0.87 ACLY (0.31) —
SCHEMBL17336985 0.87 ACLY (0.31) —
SCHEMBL23837520 0.86 PARP1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback